340B HEALTH for 340B HEALTH
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 17, 2008 | $161,917 | Replaced |
| 3rd Quarter - Amendment | Aug 20, 2009 | $161,917 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
HR 2606 and S 1376. Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARISA SCHRADER CONWAY | (No longer with organization) |
| STUART YAEL GORDON New | — |
| ANNA MANGUM | LA for Reps Viscloskey and Fascell 88-91 |
| ROBERT RECKLAUS | COS for Rep. Carolyn McCarthy 02-08 |
| TED SLAFSKY | Fellow for Sen. Dem. Policy Committee 1994 |
| JAIMIE VICKERY | LA for Reps Horn and Biggert 2000-05 |
| WILLIAM VON OEHSEN | — |
| BONNIE WEINTRAUB | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.